{"schema_version":"secwatch.filing_event.v1","accession":"0001267602-23-000113","form_type":"8-K","ticker":null,"cik":"0001267602","company_name":"ALIMERA SCIENCES INC","filed_at":"2023-08-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.393888+00:00","generated_at":"2026-06-11T09:14:34.590234+00:00","sec_items":["3.02","3.03","5.01","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Alimera Sciences completes mandatory conversion of Series B Preferred; Velan and Caligan become majority owners","bullets":["Mandatory conversion of Series B Preferred into 43,617,114 shares of common stock and Pre-Funded Warrants for 2,000,000 shares.","Following conversion, Velan holds ~26% and Caligan ~32% of common stock, constituting a change of control.","Certificate of Elimination for Series B Preferred filed with Delaware Secretary of State.","Outstanding shares: 52,418,841 common, plus 2M from Pre-Funded Warrants and 1.6M from other warrants.","Velan and Caligan retain right to designate two Board directors subject to ownership thresholds."],"urls":{"canonical":"https://secwatch.observer/filing/0001267602-23-000113","json":"https://secwatch.observer/filing/0001267602-23-000113.json","markdown":"https://secwatch.observer/filing/0001267602-23-000113.md","text":"https://secwatch.observer/filing/0001267602-23-000113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1267602/000126760223000113/0001267602-23-000113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1267602/000126760223000113/alim-20230815x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T09:14:34.590234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"75ab96f28f142342423132286c89330881ebcfc2","claim":"ALIMERA SCIENCES INC: Filed a Certificate of Elimination to remove the Certificate of Designation of Series B Convertible Preferred Stock following mandatory conversion (effective 2023-08-15).","evidence_excerpt":"the Company filed a certificate of elimination (the “Certificate of Elimination”) to the Certificate of Designation with the Secretary of State of the State of Delaware","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1267602/000126760223000113/0001267602-23-000113-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-08-15"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}